SC 13G
AN2 THERAPEUTICS, INC.
- Company
- AN2 Therapeutics, Inc.
- Filed
- April 8, 2022
- Accession Number
- 0001104659-22-044249
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →